Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Stereotactic Radiosurgery for Patients With Oligo-recurrent Disease

NCT01345552 is registered in ClinicalTrials.gov with Steven Burton as lead sponsor.

NCT NCT01345552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01345552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Stereotactic Radiosurgery for Patients With Oligo-recurrent Disease
Lead sponsor
Steven Burton
Phase
Not applicable
Overall status
Completed
Start date
June 28, 2011
Completion date
October 11, 2022
Enrollment
173 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent oligometastatic disease